No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong John Didsbury?

Dr. John Didsbury

Founder and Chief Executive Officer

T3D Therapeutics Inc

Direct Phone: (919) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

T3D Therapeutics Inc

68 T.W. Alexander Drive

Research Triangle Park, North Carolina 27709

United States

Company Description

T3D Therapeutics, Inc. is a privately-held, Research Triangle Park, NC-based company incorporated in 2013. The Company has an exclusive license to T3D-959, its lead product candidate, and a platform of structurally-related molecules. T3D Therapeutics' mis ... more

Find other employees at this company (2)

Background Information

Employment History



GlaxoSmithKline plc

Chief Scientific Officer

DARA BioSciences , Inc.

President and Chief Executive Officer

Drug Discovery Center of Innovation

Chief Executive Officer

Nuada Pharmaceuticals Inc

Chief Scientific Officer

Midatech Pharma US Inc

Associate Director Biology

Macronex Inc.


Genentech , Inc.

Assistant Professor

Duke University

President, Chief Operating Officer and Chief Scientific Officer

Redington , Inc.


PR Newswire

President and Chief Executive Officer

ChemCodes Inc.

Executive Vice President, Drug Development

Carolina Newswire




The University of Connecticut

Bachelor of Arts


University of Connecticut



Medical Microbiology

University of Vermont Medical College


Medicinal Microbiology

The University of Vermont College of Medicine

Web References (157 Total References)

T3D Therapeutics Announces Presentation of Phase 2a Preliminary Results of T3D-959 in Alzheimer's Subjects at the 2016 Alzheimer's Association International Conference [cached]

"T3D-959 is the only Alzheimer's treatment in clinical development of which we are aware that works by dually activating two nuclear receptors PPAR delta and gamma to control lipid and energy homeostasis regulating fatty acid oxidation, energy dissipation, and mitochondrial respiration," commented John Didsbury, Ph.D., Chief Executive Officer of T3D Therapeutics.

John Didsbury, Ph.D., CEO T3D Therapeutics, Inc. 1-919-237-4897
John Didsbury T3D Therapeutics, Inc.

"This is a significant milestone for ... [cached]

"This is a significant milestone for the company," said John Didsbury, T3D's CEO, in a statement.

T3D received approval from the Food and Drug Administration's Division of Neurology Products.
In March, T3D received a $1.8 million federal grant to support the Phase 2 trial, which is expected to involve 36 patients.
T3D-959 has demonstrated encouraging results in experiments with lab rats that hold out the promise that it could slow or even halt the progress of Alzheimer's, Didsbury said in March.
Founded in 2013, T3D is a virtual company that relies on outsourcing. It currently has two full-time and one-part time employee. T3D-959 was licensed in 2013 from Raleigh's Dara BioSciences, where Didsbury previously was chief scientific officer.

"This is a significant milestone for ... [cached]

"This is a significant milestone for our company," said CEO John Didsbury, a former GlaxoSmithKline executive who took his pharmaceutical company experience into the entrepreneurship realm by founding T3D in 2013.

Commenting on the award, T3D ... [cached]

Commenting on the award, T3D Therapeutics' CEO John Didsbury said, "The National Institute on Aging's support will enable us to test our novel approach to developing an Alzheimer's disease drug therapy that has the potential to slow, stop or reverse the progression of disease.

John Didsbury T3D Therapeutics, Inc.

John Didsbury is CEO of ... [cached]

John Didsbury is CEO of T3D Therapeutics, a startup company that is seeking money to carry a diabetes candidate into studies as a treatment for Alzheimer's disease.

A Research Triangle Park drug development startup company is looking to raise money to further studies of a drug candidate that was originally targeted as a treatment for diabetes as a treatment for Alzheimer's disease. T3D Therapeutics CEO Dr. John Didsbury said the start-up company licensed a diabetes drug candidate from Dara BioSciences, a Raleigh-based pharmaceutical company focused on cancer supportive care products and on developing cancer treatments.
Didsbury was formerly chief scientific officer at Dara. "It's been a personal mission of mine to identify and develop a breakthrough medicine for any disease, and this particular drug is the culmination of the search," Didsbury said of the drug candidate, which he said he believes could have multiple mechanisms for treating Alzheimer's. "It's a tough haul, but one that just requires perseverance and tenacity." Didsbury said there are "striking similarities" between diabetes and Alzheimer's. The company's drug candidate would work in multiple ways by regulating enzymes involved in Alzheimer's defects, he said. "It acts in a myriad of ways, and like I said, it regulates the levels of certain key enzymes that are involved in the pathophysiology of the disease," he said.
Through T3D Therapeutics, Didsbury is looking to raise money to try to carry the diabetes drug that his company licensed from Dara into Phase 2 trials.
Didsbury said the additional funding will allow the company to do some pre-clinical work, but they're still evaluating their financial strategy to figure out a way to pay for Phase 2 trials. He said company has applied for grants from the National Institutes of Health and other organizations.

Similar Profiles

Other People with this Name

Other people with the name Didsbury

Stephanie Didsbury
Vancouver Island University

Solita Didsbury
Solita NQ

Kimberley Didsbury

Brandon Didsbury
The Hartford Financial Services Group , Inc.

Albert's Didsbury
Albert's Didsbury

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory